Clinical Trials Logo

Anxiety Neuroses clinical trials

View clinical trials related to Anxiety Neuroses.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01226511 Completed - Anxiety Neuroses Clinical Trials

A Study in Pediatric Participants With Generalized Anxiety Disorder

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to find out if duloxetine [30-120 milligrams (mg)] given once a day by mouth for 10 weeks to children and adolescents, is better than placebo when treating Generalized Anxiety Disorder (GAD).

NCT ID: NCT00534599 Completed - Anxiety Clinical Trials

Generalized Anxiety Disorder Adjunct Study

Start date: August 2007
Phase: Phase 3
Study type: Interventional

This study is being carried out to see if extended release quetiapine fumarate (Seroquel®XL) when added to standard selective serotonin reuptake inhibitor (SSRI) / serotonin-norepinephrine reuptake inhibitor (SNRI) therapy is effective and safe for the treatment of Generalized Anxiety Disorder in patients with partial or no response to SSRI/SNRI alone or in combination with a benzodiazepine, and if so, how it compares with placebo

NCT ID: NCT00150449 Completed - Anxiety Neuroses Clinical Trials

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Start date: January 2001
Phase: Phase 3
Study type: Interventional

Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.